Evidence map›Paper›PMID 32729169›Full record

ReviewMedicinal research reviews2020

Biologically active isoquinoline alkaloids covering 2014-2018.

Xiao-Fei Shang, Cheng-Jie Yang, Susan L Morris-Natschke, Jun-Cai Li, Xiao-Dan Yin, Ying-Qian Liu, Xiao Guo, Jing-Wen Peng, Masuo Goto, Ji-Yu Zhang and 1 more

Abstract readReview
In one paragraph

Review in Medicinal research reviews, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Animals : an open access journal from MDPI · 2025
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xiao-Fei ShangSchool of Pharmacy, Lanzhou University, Lanzhou, China.
Cheng-Jie YangSchool of Pharmacy, Lanzhou University, Lanzhou, China.
Susan L Morris-NatschkeNatural Products Research Laboratories, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, USA.
Jun-Cai LiSchool of Pharmacy, Lanzhou University, Lanzhou, China.
Xiao-Dan YinSchool of Pharmacy, Lanzhou University, Lanzhou, China.
Ying-Qian LiuSchool of Pharmacy, Lanzhou University, Lanzhou, China.
Xiao GuoChinese Medicine Research and Development Center, China Medical University and Hospital, Taichung, Taiwan, ROC.
Jing-Wen PengSchool of Pharmacy, Lanzhou University, Lanzhou, China.
Masuo GotoNatural Products Research Laboratories, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, USA.
Ji-Yu ZhangLanzhou Institute of Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences, Lanzhou, China.
Kuo-Hsiung LeeNatural Products Research Laboratories, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, USA.ORCID 0000-0002-6562-0070

Funding

Novel Antitumor AgentsR01CA177584 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LEE, KUO-HSIUNG · 2013 to 2017
$1.9M
NCI NIH HHS R01 CA177584
6 · The paper itself

Abstract

Isoquinoline alkaloids, an important class of N-based heterocyclic compounds, have attracted considerable attention from researchers worldwide since the early 19th century. Over the past 200 years, many compounds from this class were isolated, and most of them and their analogs possess various bioactivities. In this review, we survey the updated literature on bioactive alkaloids and highlight research achievements of this alkaloid class during the period of 2014-2018. We reviewed over 400 molecules with a broad range of bioactivities, including antitumor, antidiabetic and its complications, antibacterial, antifungal, antiviral, antiparasitic, insecticidal, anti-inflammatory, antioxidant, neuroprotective, and other activities. This review should provide new indications or directions for the discovery of new and better drugs from the original naturally occurring isoquinoline alkaloids.

Indexed as

AlkaloidsAnti-Infective AgentsAnti-Inflammatory AgentsAntioxidantsHumansIsoquinolinesAlkaloidsAnti-Infective AgentsAnti-Inflammatory AgentsAntioxidantsIsoquinolinesantitumorberberinebiological activitiesisoquinoline alkaloids

Identifiers

PMID32729169
PMCPMC7554109

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.